Tsveta Milanova, Chief Commercial Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 1,618 shares at $21.64 ($35K) on 2024-01-24, disclosed to the SEC on 2024-01-24.
Scheduled sale ($35k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| AGIO | SELL | 2026-01-07 | $78K | — | Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $186K | — | Filing → |